{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T11:08:45Z","timestamp":1774868925736,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Russian Science Foundation (RSF)","award":["14-50-00014"],"award-info":[{"award-number":["14-50-00014"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.neuropharm.2017.12.034","type":"journal-article","created":{"date-parts":[[2017,12,24]],"date-time":"2017-12-24T01:28:39Z","timestamp":1514078919000},"page":"304-315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["C-547, a 6-methyluracil derivative with long-lasting binding and rebinding on acetylcholinesterase: Pharmacokinetic and pharmacodynamic studies"],"prefix":"10.1016","volume":"131","author":[{"given":"Konstantin","family":"Petrov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Zueva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Kovyazina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor","family":"Sedov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6922-020X","authenticated-orcid":false,"given":"Sofya","family":"Lushchekina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Kharlamova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oksana","family":"Lenina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergei","family":"Koshkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yurii","family":"Shtyrlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evgeny","family":"Nikolsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7837-3662","authenticated-orcid":false,"given":"Patrick","family":"Masson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2017.12.034_bib1","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/0896-6273(94)90331-X","article-title":"Acetylcholinesterase density and turnover number at frog neuromuscular junctions, with modeling of their role in synaptic function","volume":"12","author":"Anglister","year":"1994","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2017.12.034_bib2","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2174\/138955706776361448","article-title":"Allosteric modulation of drug binding to human serum albumin","volume":"6","author":"Ascenzi","year":"2006","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.neuropharm.2017.12.034_bib3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1196\/annals.1254.049","article-title":"Effect on T Cell recognition and immunogenicity of alanine-substituted peptides corresponding to 97-116 sequence of the rat AChR \u03b1-subunit","volume":"998","author":"Baggi","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2017.12.034_bib4","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0006-2952(00)00365-8","article-title":"Determination of the DNA sequences of acetylcholinesterase and butyrylcholinesterase from cat and demonstration of the existence of both in cat plasma","volume":"60","author":"Bartels","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.12.034_bib5","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1002\/jps.23614","article-title":"Plasma protein binding: from discovery to development","volume":"102","author":"Bohnert","year":"2013","journal-title":"J.\u00a0Pharm. Sci."},{"key":"10.1016\/j.neuropharm.2017.12.034_bib6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A\u00a0rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.neuropharm.2017.12.034_bib7","series-title":"Evaluation of Enzyme Inhibitors in Drug Discovery: a Guide for Medicinal Chemists and Pharmacologists","author":"Copeland","year":"2013"},{"key":"10.1016\/j.neuropharm.2017.12.034_bib8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ab.2014.05.031","article-title":"Optimal detection of cholinesterase activity in biological samples: modifications to the standard Ellman's assay","volume":"462","author":"Dingova","year":"2014","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.neuropharm.2017.12.034_bib9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A\u00a0new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.12.034_bib10","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/j.1552-4604.1995.tb04060.x","article-title":"Relationship between pharmacokinetics and pharmacodynamics of eptastigmine in young healthy volunteers","volume":"35","author":"Imbimbo","year":"1995","journal-title":"J.\u00a0Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.12.034_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbi.2016.02.012","article-title":"Human serum albumin reduces the potency of acetylcholinesterase inhibitor based drugs for Alzheimer's disease","volume":"249","author":"Islam","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.neuropharm.2017.12.034_bib12","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2133\/dmpk.25.254","article-title":"Pharmacokinetic and pharmacodynamic analysis of acetylcholinesterase inhibition by distigmine bromide in rats","volume":"25","author":"Ito","year":"2010","journal-title":"Drug Metabol. Pharmacokinet."},{"key":"10.1016\/j.neuropharm.2017.12.034_bib13","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1042\/BCJ20160084","article-title":"Slow-binding inhibition of acetylcholinesterase by an alkylammonium derivative of 6-methyluracil: mechanism and possible advantages for myasthenia gravis treatment","volume":"473","author":"Kharlamova","year":"2016","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuropharm.2017.12.034_bib14","doi-asserted-by":"crossref","first-page":"10347","DOI":"10.1074\/jbc.M507502200","article-title":"Acetylcholinesterase dynamics at the neuromuscular junction of live animals","volume":"281","author":"Krejci","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2017.12.034_bib15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11910-010-0151-1","article-title":"Treatment of myasthenia gravis","volume":"11","author":"Kumar","year":"2011","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.neuropharm.2017.12.034_bib16","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/iub.1682","article-title":"Human serum albumin: a modulator of cannabinoid drugs","volume":"69","author":"Leboffe","year":"2017","journal-title":"IUBMB Life"},{"key":"10.1016\/j.neuropharm.2017.12.034_bib17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejphar.2012.05.010","article-title":"Effect of tissue-specific acetylcholinesterase inhibitor C-547 on alpha3beta4 and alphabetaepsilondelta acetylcholine receptors in COS cells","volume":"688","author":"Lindovsky","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.12.034_bib18","first-page":"34","article-title":"Understanding the hysteresis loop conundrum in pharmacokinetic\/pharmacodynamic relationships","volume":"17","author":"Louizos","year":"2014","journal-title":"J.\u00a0Pharm. Pharmaceut. Sci."},{"key":"10.1016\/j.neuropharm.2017.12.034_bib19","first-page":"229","article-title":"Computational exploration of reactivity of 6-methyluracil\/imidazole-2-carbaldehyde oxime conjugate","volume":"7","author":"Lushchekina","year":"2017","journal-title":"Bio. Nano Sci."},{"key":"10.1016\/j.neuropharm.2017.12.034_bib20","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.abb.2016.02.010","article-title":"Slow-binding inhibition of cholinesterases, pharmacological and toxicological relevance","volume":"593","author":"Masson","year":"2016","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.neuropharm.2017.12.034_bib21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/7854_2016_18","article-title":"Decoding the structure of abuse potential for new psychoactive substances: structure-activity relationships for abuse-related effects of 4-substituted methcathinone analogs","volume":"32","author":"Negus","year":"2017","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.12.034_bib22","doi-asserted-by":"crossref","first-page":"11870","DOI":"10.1523\/JNEUROSCI.0329-14.2014","article-title":"Schwann cells sense and control acetylcholine spillover at the neuromuscular junction by \u03b17 nicotinic receptors and butyrylcholinesterase","volume":"34","author":"Petrov","year":"2014","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.12.034_bib23","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1476-5381.2011.01211.x","article-title":"Different sensitivities of rat skeletal muscles and brain to novel anti-cholinesterase agents, alkylammonium derivatives of 6-methyluracil (ADEMS)","volume":"163","author":"Petrov","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.12.034_bib24","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/jps.24571","article-title":"The role of extracellular binding proteins in the cellular uptake of drugs: impact on quantitative in\u00a0vitro-to-in\u00a0vivo extrapolations of toxicity and efficacy in physiologically based pharmacokinetic-pharmacodynamic research","volume":"105","author":"Poulin","year":"2016","journal-title":"J.\u00a0Pharm. Sci."},{"key":"10.1016\/j.neuropharm.2017.12.034_bib25","first-page":"161","article-title":"New class cholinesterase inhibitors: tetralkylammonium derivatives of 6-methyluracil and alloxazine doklady Chemistry (translation of the chemistry section of doklady akademii nauk)","volume":"362","author":"Reznik","year":"1998"},{"key":"10.1016\/j.neuropharm.2017.12.034_bib26","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1083\/jcb.42.1.122","article-title":"Electron microscope radioautography as a quantitative tool in enzyme cytochemistry: II. The distribution of DFP-reactive sites at motor Endplates of A Vertebrate twitch muscle","volume":"42","author":"Salpeter","year":"1969","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.neuropharm.2017.12.034_bib27","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1083\/jcb.96.6.1781","article-title":"Distribution and turnover rate of acetylcholine receptors throughout the junction folds at a vertebrate neuromuscular junction","volume":"96","author":"Salpeter","year":"1983","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.neuropharm.2017.12.034_bib28","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1039\/C4MD00225C","article-title":"Macrocyclic derivatives of 6-methyluracil as ligands of the peripheral anionic site of acetylcholinesterase","volume":"5","author":"Semenov","year":"2014","journal-title":"Med. Chem. Comm."},{"key":"10.1016\/j.neuropharm.2017.12.034_bib29","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1002\/cmdc.201500334","article-title":"6-methyluracil derivatives as bifunctional acetylcholinesterase inhibitors for the treatment of Alzheimer's disease","volume":"10","author":"Semenov","year":"2015","journal-title":"ChemMedChem"},{"key":"10.1016\/j.neuropharm.2017.12.034_bib30","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cbi.2010.01.028","article-title":"Biosensor analysis of blood esterases for organophosphorus compounds exposure assessment: approaches to simultaneous determination of several esterases","volume":"187","author":"Sigolaeva","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.neuropharm.2017.12.034_bib31","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/neu.10139","article-title":"The nicotinic receptor ligand binding domain","volume":"53","author":"Sine","year":"2002","journal-title":"J.\u00a0Neurobiol."},{"key":"10.1016\/j.neuropharm.2017.12.034_bib32","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1517\/17425247.2015.993313","article-title":"Albumin and its application in drug delivery","volume":"12","author":"Sleep","year":"2015","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.neuropharm.2017.12.034_bib33","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF03189975","article-title":"Pharmacokinetic studies of ambenonium chloride in patients with myasthenia gravis","volume":"16","author":"Tharasse-Bloch","year":"1991","journal-title":"Eur. J. Drug Metab. Pharmokinet."},{"key":"10.1016\/j.neuropharm.2017.12.034_bib34","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1517\/17460441.2013.777424","article-title":"In silico prediction of human serum albumin binding for drug leads","volume":"8","author":"Vallianatou","year":"2013","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.neuropharm.2017.12.034_bib35","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1517\/17460441.2015.1067196","article-title":"On the 'micro'-pharmacodynamic and pharmacokinetic mechanisms that contribute to long-lasting drug action","volume":"10","author":"Vauquelin","year":"2015","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.neuropharm.2017.12.034_bib36","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1111\/bph.13504","article-title":"Effects of target binding kinetics on in\u00a0vivo drug efficacy: koff, kon and rebinding","volume":"173","author":"Vauquelin","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.12.034_bib37","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1476-5381.2010.00936.x","article-title":"Long-lasting target binding and rebinding as mechanisms to prolong in\u00a0vivo drug action","volume":"161","author":"Vauquelin","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.12.034_bib38","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0009-8981(99)00144-8","article-title":"Improved determination of acetylcholinesterase activity in human whole blood","volume":"288","author":"Worek","year":"1999","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.neuropharm.2017.12.034_bib39","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/bdd.2510120807","article-title":"Pharmacokinetics of ambenonium, a reversible cholinesterase inhibitor, in rats","volume":"12","author":"Yamamoto","year":"1991","journal-title":"Biopharm Drug Dispos."},{"key":"10.1016\/j.neuropharm.2017.12.034_bib40","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1248\/bpb.18.1292","article-title":"Comparative pharmacokinetics of four cholinesterase inhibitors in rats","volume":"18","author":"Yamamoto","year":"1995","journal-title":"Biol. Pharmaceut. Bull."},{"key":"10.1016\/j.neuropharm.2017.12.034_bib41","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1016\/j.bbagen.2013.05.005","article-title":"Albumin-drug interaction and its clinical implication","volume":"1830","author":"Yamasaki","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2017.12.034_bib42","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1208\/s12248-012-9436-4","article-title":"Translational pharmacokinetic-pharmacodynamic modeling from nonclinical to clinical development: a case study of anticancer drug, crizotinib","volume":"15","author":"Yamazaki","year":"2013","journal-title":"AAPS J."},{"key":"10.1016\/j.neuropharm.2017.12.034_bib43","doi-asserted-by":"crossref","first-page":"13630","DOI":"10.1016\/S0021-9258(18)33494-X","article-title":"Cellular localization of the molecular forms of acetylcholinesterase in rat diaphragm","volume":"257","author":"Younkin","year":"1982","journal-title":"J.\u00a0Biol. Chem."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817306317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817306317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T04:20:50Z","timestamp":1660191650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390817306317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":43,"alternative-id":["S0028390817306317"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.12.034","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"C-547, a 6-methyluracil derivative with long-lasting binding and rebinding on acetylcholinesterase: Pharmacokinetic and pharmacodynamic studies","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.12.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}